Lloyds' Narrow Moat Isn't Drying Up
Morningstar - Seeking Alpha - Mon Dec 22, 1:31PM CST
By Erin Davis With its third-quarter results, Lloyds Banking Group (NYSE: LYG ) announced that it plans to close 200 branches as its customers increasingly embrace digital banking platforms. This brings to the forefront the question of whether the...
BCS: 15.13 (+0.04), SAN: 8.72 (+0.05), HSBC: 47.71 (+0.18), RBS: 12.31 (+0.14), LYG: 4.73 (+0.01)
2 Reasons On Why European Stocks Have Room To Grow
David Hunkar - Seeking Alpha - Wed Dec 17, 10:51AM CST
European stocks have been laggards this years relative to the decent performance of U.S. stocks. However moving forward, European stocks have better growth potential compared to their American peers for a variety of reasons two of which are discussed...
E: 36.10 (-0.25), SAN: 8.72 (+0.05), TEF: 14.81 (-0.02), SNY: 46.35 (+0.50)
GE Offers 2015 Outlook with Continued Industrial Focus - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 9:00AM CST
General Electric Company (GE) recently presented its first specific earnings guidance in five years when it offered its outlook for 2015 at an investor presentation.
SAN: 8.72 (+0.05), GE: 25.83 (-0.05), SYF: 30.11 (+0.11), CSL: 91.36 (+0.04)
Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol
PR Newswire - Mon Dec 15, 7:00AM CST
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi US (EURONEXT: SAN and NYSE: SNY) are collaborating with nationally-recognized patient and professional heart disease organizations to launch Cholesterol Counts, an awareness program that will gauge how much Americans know about cholesterol, their numbers, and the risks associated with high LDL-C (bad cholesterol). American adults are encouraged to visit www.CholesterolCounts.com to take a brief poll and answer a few key questions about their health. The results of the poll will provide a snapshot of cholesterol awareness levels across the country and be revealed in 2015.
SAN: 8.72 (+0.05), SNY: 46.35 (+0.50), REGN: 400.12 (+6.07)
Santander Universities launches the Santander Grants app for students
PR Newswire - Fri Dec 12, 3:26PM CST
University students from over 1,100 universities and research centers around the world now have access to the new Santander Grants app launched by Santander's Santander Universities Global Division, which is free to download from the Apple Store: https://itunes.apple.com/es/app/becas-santand...18432?mt=8 and Google Play: https://play.google.com/store/apps/details?id...ssantander
SAN: 8.72 (+0.05)
Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults
PR Newswire - Fri Dec 12, 7:00AM CST
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental biologics license application (sBLA) for Fluzone Intradermal Quadrivalent vaccine. Fluzone Intradermal vaccine, which has been available in trivalent formulation for three years, is now available in a quadrivalent formulation to help protect against four strains of influenza virus. Fluzone Intradermal Quadrivalent vaccine is indicated for adults 18 through 64 years of age for active immunization for the prevention of influenza ("the flu"
SAN: 8.72 (+0.05), SNY: 46.35 (+0.50)
Lawsky takes aim at auto lenders
Seeking Alpha - at Seeking Alpha - Thu Dec 11, 3:11PM CST
SC: 20.09 (-0.19), SAN: 8.72 (+0.05), F: 15.30 (-0.03), TD: 47.61 (+0.20), HMC: 30.37 (+0.14)
Must-See Charts: How to Trade IBM, Santander and More
at The Street - Thu Dec 11, 10:08AM CST
Here's a close technical look at five big stocks to trade for gains.
SAN: 8.72 (+0.05), DFS: 65.95 (-0.22), IBM: 161.82 (-0.42), CTL: 40.18 (-0.05), ADBE: 74.74 (+0.36)
EWP: Cheap And Unloved, Spanish Stocks Are A Buy
Charles Lewis Sizemore, CFA - Seeking Alpha - Wed Dec 10, 5:38PM CST
In the last month of 2014, investors have two chief concerns: lackluster Black Friday sales and the sudden collapse in crude oil prices. On the surface, neither of these should be causes of major concern. Retail sales came in lower than expected on...
SAN: 8.72 (+0.05), TEF: 14.81 (-0.02), EWP: 36.13 (+0.22), BBVA: 9.79 (+0.01)
Banco Santander Set to Possibly Rebound After Yesterday's Selloff of 2.02%
Comtex SmarTrend(R) - Tue Dec 09, 5:17PM CST
Banco Santander (NYSE:SAN) traded in a range yesterday that spanned from a low of $8.66 to a high of $8.76. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $8.79 on volume of 8.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SAN: 8.72 (+0.05)
Ana Botin presents the Universia Rio 2014 Charter at the 24th Ibero-American Conference of Heads of State
PR Newswire - Tue Dec 09, 4:24PM CST
Banco Santander and Universia Executive Chairman Ana Botin and a delegation of Ibero-American vice-chancellors presented the Universia Rio 2014 Charter to Mexican President Enrique Pena Nieto, Spain's King Felipe VI and Ibero-American Secretary General Rebeca Grynspan at the Ibero-American Conference of Heads of State held in Veracruz, Mexico.
SAN: 8.72 (+0.05)
Report: Santander considering taking U.S. unit back
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 9:23AM CST
SC: 20.09 (-0.19), SAN: 8.72 (+0.05)
The 4 Worst Bank Stocks of 2014
Motley Fool Staff - Motley Fool - Fri Dec 05, 6:58AM CST
Most of the banking industry has performed pretty well this year. Investment banking revenues are up, thanks to the high M&A and IPO activity resulting from the strong stock market. And, consumer banking activity like lending and brokerage...
BCS: 15.13 (+0.04), SAN: 8.72 (+0.05), NBG: 1.95 (+0.06), LYG: 4.73 (+0.01)
After Yesterday's Decline of 1.66%, Banco Santander Offers Investors Better Value
Comtex SmarTrend(R) - Thu Dec 04, 4:26PM CST
Banco Santander (NYSE:SAN) traded in a range yesterday that spanned from a low of $8.79 to a high of $8.94. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $8.86 on volume of 10.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SAN: 8.72 (+0.05)
Santander: Why Was The CEO Fired? And What Does That Mean
Nelson Alves - at Seeking Alpha - Thu Dec 04, 1:15PM CST
SAN: 8.72 (+0.05)
Fitch To Withdraw Ratings Of Santander Holdings USA And Santander Bank
PR Newswire - Thu Dec 04, 9:00AM CST
Santander Holdings USA, Inc. ("SHUSA"
SAN: 8.72 (+0.05), SC: 20.09 (-0.19)
GE Contemplates Divesture of Polish Bank Unit Ownership - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 5:30PM CST
In yet another significant step to reduce credit risks, General Electric Company (GE) is planning to divest its ownership stake in Polish Bank BPH SA.
SAN: 8.72 (+0.05), GE: 25.83 (-0.05), SYF: 30.11 (+0.11), CSL: 91.36 (+0.04)
First MS Patients in the U.S. Receive Genzyme's Lemtrada Following FDA Approval
Business Wire - Wed Dec 03, 7:01AM CST
Genzyme, a Sanofi company, today announced that the first U.S. patients have initiated treatment with Lemtrada(R) (alemtuzumab) in the commercial setting following its November 14th FDA approval for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.
SAN: 8.72 (+0.05), SNY: 46.35 (+0.50)
Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection
PR Newswire - Tue Dec 02, 7:35AM CST
Sanofi announced today that following a priority review, the U.S. Food and Drug Administration has approved Priftin® (rifapentine) in combination with isoniazid (INH) for a new indication for the treatment of latent tuberculosis infection (LTBI) in patients two years of age and older at high risk of progression to tuberculosis (TB) disease. Priftin is an antimycobacterial that has been approved since 1998, in combination with one or more antituberculosis drugs, for the treatment of active pulmonary TB caused by Mycobacterium tuberculosis.
SAN: 8.72 (+0.05), SNY: 46.35 (+0.50)
Diversified Banks Equities Under the Scanner - Banco Bilbao Vizcaya Argentaria, Grupo Financiero Santander Mexico, Banco Santander, Lloyds Banking, and Royal Bank of Scotland
PR Newswire - Tue Dec 02, 7:30AM CST
Investor-Edge has initiated coverage on the following equities: Banco Bilbao Vizcaya Argentaria S.A. (NYSE: BBVA), Grupo Financiero Santander Mexico SAB de C.V. (NYSE: BSMX), Banco Santander S.A. (NYSE: SAN), Lloyds Banking Group PLC (NYSE: LYG), and Royal Bank of Scotland Group PLC (NYSE: RBS). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, December 01, 2014, the NASDAQ Composite ended at 4,727.35, down 1.34%, the Dow Jones Industrial Average edged 0.29% lower, to finish the day at 17,776.80, and the S&P 500 closed at 2,053.44, down 0.68%. The losses were broad based as eight out of ten sectors ended the session in negative. The S&P 500 Financials Sector Index ended the day at 325.64, down 0.72%, while the index has advanced 3.71% in the previous three months. Register for your complimentary reports on these five stocks at:
SAN: 8.72 (+0.05), RBS: 12.31 (+0.14), LYG: 4.73 (+0.01), BSMX: 10.19 (-0.05), BBVA: 9.79 (+0.01)